EichorEICHOR
Condition: Atopic Dermatosis Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Atopic Dermatosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Metabolic Profiling of Immune Responses in Immune-mediated Diseases
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04864886AI App for Management of Atopic Dermatitis
NA · 1 location(s) · West China Hospital · NCT06362629Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · 108 location(s) · Galderma R&D · NCT06988605Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Phase 2 · 1 location(s) · Corvus Pharmaceuticals, Inc. · NCT07441395Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis
Phase N/A · 1 location(s) · University Hospital Schleswig-Holstein · NCT03361215A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis
Phase 2 · 1 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT07330934A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06732414Role of Interleukin-13 Pathways on Pain and Itch Sensitivity
NA · 3 location(s) · Aalborg University · NCT06503510Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Level
Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT03835767Sand Play - the Effect of Biodiversity Exposure on Atopic Dermatitis
NA · 2 location(s) · Natural Resources Institute Finland · NCT06390696Characterization of Chronic Hand Eczema
Phase N/A · 1 location(s) · Dr. Robert Bissonnette · NCT05026554A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Phase 2 · 23 location(s) · Inmagene LLC · NCT07037901China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
Phase N/A · 1 location(s) · Peking University First Hospital · NCT05316805Virtual Reality for Pain Management During Dupilumab Injection
NA · 2 location(s) · St. Justine's Hospital · NCT06182436Ethnic Differences in Mechanisms of Action of Dupilumab
Phase 4 · 1 location(s) · University of Michigan · NCT05268107Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
Phase N/A · 4 location(s) · Castle Biosciences Incorporated · NCT07645820Reflectance Confocal Microscopy Evaluation of Skin Structure of Patients With Atopic Dermatitis Under Nemolizumab
Phase N/A · 1 location(s) · Hôpitaux Drôme Nord · NCT07730788A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions (Eczema Are
Phase N/A · 9 location(s) · Sanofi · NCT06192563This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · 79 location(s) · Sanofi · NCT07290803Effects of Treatments on Atopic Dermatitis
Phase 2 · 1 location(s) · National Institute of Arthritis and Musculoskeletal and Skin · NCT01631617A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atop
Phase 3 · 46 location(s) · Organon and Co · NCT07265479Nationwide Research on the Rewilding of Kindergarten Yards
NA · 2 location(s) · Natural Resources Institute Finland · NCT06390878Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopi
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07262983Safety and Efficacy of Fecal Microbiota Transplantation
NA · 1 location(s) · Chinese University of Hong Kong · NCT04014413Spanish Academy of Dermatology and Venereology Registry of Atopic Dermatitis Therapy
Phase N/A · 9 location(s) · Fundación Academia Española de Dermatología · NCT05674695Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies
Phase N/A · 1 location(s) · King's College London · NCT07228962Registry for Systemic Eczema Treatments
Phase N/A · 1 location(s) · Johns Hopkins University · NCT06136767Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation
Phase N/A · 1 location(s) · Charite University, Berlin, Germany · NCT05098821Prebiotic Effects of Mulberry Fruit in Children and Adolescents With Atopic Dermatitis
NA · 2 location(s) · Taipei Medical University Shuang Ho Hospital · NCT06636240A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
Phase 1 · 14 location(s) · Bambusa Therapeutics · NCT06808477
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.